## Abstract A series of 14 children with bone marrow or testicular recurrence of acute lymphoblastic leukemia (ALL) and treated with pulsed combined chemotherapy incorporating doxorubicin is reviewed. All had been previously adequately treated according to established leukemia protocols. Median dis
Prolymphocytic leukemia: Treatment with combination chemotherapy to include doxorubicin
β Scribed by H. Grant Taylor; William M. Butler; Joanne Rhoads; Donald S. Karcher; Barbara Detrick-Hooks
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 800 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Our objective was to assess the efficacy of a standard dose ifosfamide and doxorubicin containing regimen in the treatment of advanced soft tissue sarcomas. Forty consecutive patients with a median age of 35.5 years were treated. Ifosfamide was administered at a dose of 2.5 g/m 2 /day as 72-hour con
The authors developed a therapeutic regimen in which 33 patients aged I I to 61 years (mean 2 SE, 35.9 t 2.3 years) with acute myeloid leukemia (AML) were given intensive induction chemotherapy with Adriamycin (doxorubicin) (ADM), vincristine (VCR) and cytosine arabinoside (ARA-C). Twenty-nine of th